Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Albert Edge
Massachusetts Eye and Ear Infirmary, Department: Na
Should you be removed from our database? Contact us at [email protected]. Read more below.
Decibel Therapeutics, Inc.
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Decibel Therapeutics, Inc. discovers and develops medicines to protect, repair, and restore hearing. It primarily focuses on hearing disorders, including noise-induced hearing loss; residual hearing preservation or improved sound fidelity with cochlear implants; presbycusis or age-related hearing loss; tinnitus, a persistent ringing in the ears; and genetic hearing loss. The focus of this grant is to further investigate and determine the role of signaling pathways in specific cochlear cells in the regeneration of lost hair cells, the results of which could lead to new ways to treat hearing loss. Dr. Edge is a co-founder of this company and we have determined that results of this grant will directly impact the company's ability to grow.
Wnt Signaling in Hair Cell Generation from Supporting Cells
Hair cells of the inner ear are responsible for detection of sound and motion. Loss of hair cells can be caused by excess noise, exposure to toxins, and aging, and is a major cause of hearing and balance disorders. In this proposal, we determine the role of signaling pathways in specific cochlear cells in the regeneration of lost hair cells. Te results could lead to new ways to treat these debilitating conditions.
Filed on January 06, 2016.
Tell us what you know about Albert Edge's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Albert Edge filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Albert Edge | Massachusetts Eye and Ear Infirmary | Conflict of Interest | Decibel Therapeutics, Inc. | $40,000 - $59,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.